NewsBenzingaArtelo Bioscience To Present Data On ART26.12 Program At IASP 2026 World Congress On Pain, October 26–30; Growing Body Of Data Supports ART26.12’s Potential As A Novel, Non-Opioid Treatment For Pain Ahead Of Planned Multiple Ascending Dose Study Artelo Bioscience To Present Data On ART26.12 Program At IASP 2026 World Congress On Pain, October 26–30; Growing Body Of Data Supports ART26.12’s Potential As A Novel, Non-Opioid Treatment For Pain Ahead Of Planned Multiple Ascending Dose Study Benzinga 2026.10.26 11:58 (GMT+0) Open on Benzinga Other news Top Wall Street Forecasters Revamp PayPal Expectations Ahead Of Q3 Earnings Pharming Affirms FY2026 Sales Guidance of $380.000M-$390.000M vs $383.333M Est Elizabeth Warren Sees 2008-Style Warning Signs in AI Boom — ‘Trump’s Regulators Are Choosing to Look the Other Way’ Binance Margin to Remove RE/USD1, 币安人生/U and Other Trading Pairs on October 30 ‘Where Are The Cybercabs?’ Tesla Investor Ross Gerber Takes Aim at Elon Musk as Amazon’s Zoox Eyes Expansion With Santa Monica Deal for 150 Robotaxis Reported Earlier, Five Star Q3 EPS $0.92 Beats $0.85 Estimate, Sales $52.620M Beat $50.069M Estimate
Elizabeth Warren Sees 2008-Style Warning Signs in AI Boom — ‘Trump’s Regulators Are Choosing to Look the Other Way’
‘Where Are The Cybercabs?’ Tesla Investor Ross Gerber Takes Aim at Elon Musk as Amazon’s Zoox Eyes Expansion With Santa Monica Deal for 150 Robotaxis
